Refine Results
- Products
- Content Type
- Analysis Platform
- Language
1 - 13 of 13 results
The Agilent workflow solution for implementing an elemental impurities analysis capability in compliance with USP / and ICH Q3D.
| English (United States) | Complete (PDF) |
|---|
This application note describes the validation of a procedure for the measurement of elemental impurities in sterile artificial tear eye drops (SATED).
Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals
Study using USP method quantified 24 elements via ICP-MS in pharmaceutical materials dissolved in organic solvent (DMSO)
The analysis of 24 elements in Aspirin samples using an Agilent ICP-OES and the analytical procedures and validation studies required by USP / ICH-Q3D.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
SDA Compliance for Agilent ICP-MS Systems
Application note for the determination of K, Na, and Zn in Albumin using Flame AAS
Application note for new high performance graphite furnace tube for determination of lead in blood
New limits for elemental impurities in pharmaceutical materials and dietary supplements have been released by the USP and ICH.
Expanded support for USP / and ICH Q3D methods supports compliance with elemental impurity analysis in pharmaceutical materials via ICP-OES
White paper discussing the important considerations for implementing an elemental impurities analysis capability in compliance with USP / and ICH Q3D.
White paper discussing the important considerations for implementing an elemental impurities analysis capability in compliance with USP / and ICH Q3D.
ICH and USP tests for elemental impurities provide better indication of potentially toxic contaminants. Learn more...